Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

Nir Giladi from TAU’s Faculty of Medical and Health Sciences and the Tel Aviv Sourasky Medical Center, as well as other researchers from TAU and the University of Haifa. The study was backed by the ...

Aug. 19, 2024 — A small feasibility study found that an implanted device regulated by the body's brain activity could provide continual and improved treatment for the symptoms of Parkinson's ...

The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.

The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not ...

There is a new and promising form of treatment for those suffering from Parkinson’s Disease and it could be as simple as ...

The Parkinson’s disease (PD) therapeutic landscape is heavily genericized, leaving substantial unmet needs in neuroprotective ...

About 7 million Americans live with chronic neurodegenerative diseases such as Parkinson’s disease, amyotrophic lateral ...

Treatments targeting alpha-synuclein aggregation account for 26% of the 7MM' pipeline disease-modifying therapies for ...

Early initiation of pimavanserin among patients with Parkinson disease psychosis were more likely to experience complete symptom resolution.